Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Exploring markers of immunoresponsiveness in papillary thyroid carcinoma and future treatment strategies.

Journal for immunotherapy of cancer - 29 Jul 2024

Mohanty Atish, Afkhami Michelle, Reyes Amanda, Pharaon Rebecca, Yin Holly, Li Haiqing, Do Dana, Bell Diana, Nam Arin, Chang Sue, Gernon Thomas, Kang Robert, Amini Arya, Sampath Sagus, Kulkarni Prakash, Pillai Raju, Villaflor Vicky, Salgia Ravi, Maghami Ellie, Massarelli Erminia

Abstract excerpt

BACKGROUND: The study summarizes the potential use of immunotherapy for BRAF-mutated papillary thyroid cancer (PTC) by analyzing the immune profile of City of Hope PTC patient samples and comparing them to the thyroid dataset available in the TCGA database. MATERIALS AND METHODS: PTC cases with available formalin-fixed paraffin-embedded archived tumor tissue were identified. RNA was extracted from the tumor...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Cell Line, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunotherapy

Share to Mutation

Share to Proto-Oncogene Proteins B-raf

Share to Thyroid Cancer, Papillary

Share to Thyroid Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 39074963
DOI: 10.1136/jitc-2023-008505
PMCID: PMC11288153

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Exploring markers of immunoresponsiveness in papillary thyroid carcinoma and future treatment strategies.PMID 39074963Read ↗

Distinct molecular subtypes of papillary thyroid carcinoma and gene signature with diagnostic capability.Semantic proximity Read ↗

Immune Gene Signature Delineates a Subclass of Papillary Thyroid Cancer with Unfavorable Clinical OutcomesSemantic proximity Read ↗

Transcriptomic signatures associated with autoimmune thyroiditis in papillary thyroid carcinoma and cancer immunotherapy-induced thyroid dysfunctionSemantic proximity Read ↗

Development an Immune-Associated LncRNA Prognostic Index for Papillary Thyroid CancerSemantic proximity Read ↗

BRAFV600E/pTERT double mutated papillary thyroid cancers exhibit immune gene suppression.Semantic proximity Read ↗

DPP4 Promotes Papillary Thyroid Cancer Progression by Regulating the Infiltration and Exhaustion of CD8+ T cellsSemantic proximity Read ↗

HLA-restricted Epitopes Prediction of Papillary Thyroid CarcinomaSemantic proximity Read ↗

BRAF V600E in papillary thyroid carcinoma is associated with increased programmed death ligand 1 expression and suppressive immune cell infiltration.Semantic proximity Read ↗

The Prognostic Value and Potential Immune Mechanisms of lncRNAs Related to Immunogenic Cell Death in Papillary Thyroid CarcinomaSemantic proximity Read ↗

Immune cell confrontation in the papillary thyroid carcinoma microenvironmentSemantic proximity Read ↗

Transcriptomic Analysis of Papillary Thyroid Cancer: A Focus on Immune-Subtyping, Oncogenic Fusion, and RecurrenceSemantic proximity Read ↗

Diagnostic and prognostic value of tumor-infiltrating B cells in lymph node metastases of papillary thyroid carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.